Member access

4-Traders Homepage  >  Shares  >  Nyse  >  AbbVie Inc    ABBV   US00287Y1091

ABBVIE INC (ABBV)

26
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
04/16/2014 04/17/2014 04/21/2014 04/22/2014 04/23/2014 Date
48.12(c) 48.55(c) 49.43(c) 50.01(c) 50.14(c) Last
7 150 999 6 196 807 4 444 955 6 613 231 6 578 335 Volume
+0.54% +0.89% +1.81% +1.17% +0.26% Change
More quotes
Company
AbbVie, Inc. is a research-based biopharmaceutical company. It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products. The company's products are used to treat rheumatoid arthritis, psoriasis, Crohn's disease, HIV, cystic fibrosis... 
Surperformance© rating of AbbVie Inc
Trading Rating : Investor Rating :
More about the company
Chart ABBVIE INC
Duration : Period :
AbbVie Inc Technical Analysis Chart | ABBV | US00287Y1091 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 19 160 M
EBIT 2014 6 648 M
Net income 2014 4 599 M
Debt 2014 2 833 M
Yield 2014 3,32%
Sales 2015 20 994 M
EBIT 2015 7 766 M
Net income 2015 5 738 M
Finance 2015 240 M
Yield 2015 3,54%
PER 2014 16,81
PER 2015 13,23
EV / Sales 2014 4,31x
EV / Sales 2015 3,79x
Capitalization 79 818 M
More Financials
Latest news on ABBVIE INC
1d ago ABBVIE : "Prevention of Kidney Injury Disease" in Patent Application Approval Pr..
1d ago ABBVIE : to Present Data on Investigational Compounds at the 2014 American Socie..
4d agoDJMARKET SNAPSHOT : Long View On Stocks Is Best During Weak Earnings Season
6d ago ABBVIE : Assigned Patent
04/17 ABBVIE : Releases Results from Hepatitis C Study at the 2014 International Liver..
04/16 ABBVIE : Application Now Open for Students with Cystic Fibrosis for the 2014 Abb..
04/16DJAbbott Labs Profit Falls 31%
04/16 ENANTA PHARMACEUTICALS : Posts Detailed Data from TURQUOISE-II Study in Chronic ..
04/15 ABBVIE : Announces Initiation of Pivotal Phase III Study of Veliparib (ABT-888) ..
04/15 ABBVIE : Mounting AndroGel Lawsuits Prompt Petition for Federal Multidistrict Li..
04/12 ABBVIE : to Present Late-Breaking Results from TURQUOISE-II Study in Chronic Hep..
04/11 ABBVIE : Assigned Patent
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Technical analysis
Income Statement Evolution
AbbVie Inc : Income Statement Evolution
More Financials
EPS Revisions
AbbVie Inc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF